How do you approach a potential drug holiday in a patient with osteoporosis who has had improvement in BMD after several years of denosumab therapy?
Answer from: at Academic Institution
If a patient on denosumab has achieved BMD of the spine and hip that are in the high osteopenia range or normal BMDs (T score above -1), and the patient has not fractured and is not on glucocorticoids or hormone depleting agents for breast or prostate cancer, can have denosumab stopped. However, at ...
Comments
at Steven L. Feldman, MD How would you approach this issue if the patient's...
at The Baton Rouge Clinic What if the patient had previously been on IV recl...
How would you approach this issue if the patient's...
What if the patient had previously been on IV recl...